Two timed walk tests were found to be highly reliable for the measurement of exercise capacity in…
Ana Pena, PhD
Ana is a molecular biologist with a passion for communication and discovery. As a science writer, her goal is to provide readers, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Thymoma, a tumor of the thymus gland that can be benign or malignant, elevates ocular…
Robot-assisted surgery to remove the thymus gland is considered a safe method of performing a thymectomy…
Multidisciplinary Support Is Key to Managing Pregnancy in Myasthenia Gravis, Case Report Highlights
Early support from a diverse team of clinicians is key to successfully managing pregnancy in women with…
Treatment with Rituxan (rituximab)Â provided sustained clinical improvement, increased muscle strength, and extended the…
Genetic Variants, Other Medications Influence Optimal Dose of Prograf in MG Patients, Study Suggests
The therapeutic effects of Prograf (tacrolimus) in myasthenia gravis (MG) patients are influenced not…
People with refractory myasthenia gravis are at a higher risk of myasthenic crises and of being hospitalized compared to…